Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Catalog Technologies Inc. focuses on the Biotechnology & Pharmaceuticals technology area and has 3 pending office actions. These actions are handled by 3 distinct examiners. Despite having 3 distinct examiners, the work is concentrated within 2 distinct art units.
TSUI, YUNG-SHENG M is the busiest examiner for this portfolio, with 1 pending office action. Since each of the 3 pending office actions is handled by a different individual, the workload is evenly distributed. This means no single examiner has a dominant influence over the active matters.
The use of 2 distinct art units suggests some level of technical overlap in the subject matter. Practitioners should look for shared themes between the actions, even though they are assigned to different examiners. The prosecution strategy requires managing separate examiner relationships across the 2 distinct art units. This structure allows the company to test different arguments across a limited number of technical groups while interacting with TSUI, YUNG-SHENG M.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TSUI, YUNG-SHENG M | 1 | 66.5% | +6.3% |
| WOITACH, JOSEPH T | 1 | 49.5% | +27.4% |
| ASIAMAH, ABENA ASANTEWAA | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18570236 | PROCESSING METHODS FOR NUCLEIC ACID DATA STORAGE | TSUI, YUNG-SHENG M | — |
| 18282825 | FIXED POINT NUMBER REPRESENTATION AND COMPUTATION CIRCUITS | WOITACH, JOSEPH T | — |
| 18024909 | SYSTEMS AND METHODS FOR WRITING BY SEQUENCING OF NUCLEIC ACIDS | ASIAMAH, ABENA ASANTEWAA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18282825 | FIXED POINT NUMBER REPRESENTATION AND COMPUTATION CIRCUITS | WOITACH, JOSEPH T | — |
| Art Unit | Apps |
|---|---|
| 1684 | 2 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18570236 | PROCESSING METHODS FOR NUCLEIC ACID DATA STORAGE | TSUI, YUNG-SHENG M | 1684 | §103§112 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18282825 | FIXED POINT NUMBER REPRESENTATION AND COMPUTATION CIRCUITS | WOITACH, JOSEPH T | 1684 | §101§112 | Non-Final OA | — | Pending | Sep 19, 2023 |
| 18024909 | SYSTEMS AND METHODS FOR WRITING BY SEQUENCING OF NUCLEIC ACIDS | ASIAMAH, ABENA ASANTEWAA | 1685 | §101§103 | Non-Final OA | — | Pending | Mar 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCatalog Technologies Inc. has 3 pending office actions as of October 2026, spread across 2 art units and 3 examiners.
Yung-Sheng M Tsui has the most, with 1 of Catalog Technologies Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
